Stocks and Investing Stocks and Investing
Wed, February 16, 2022
Tue, February 15, 2022
Mon, February 14, 2022
Fri, February 11, 2022

Raghuram Selvaraju Maintained (ADXN) at Strong Buy with Decreased Target to $420 on, Feb 11th, 2022


Published on 2024-10-27 19:39:19 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Addex Therapeutics Ltd" (ADXN) at Strong Buy with Decreased Target from $560 to $420 on, Feb 11th, 2022.

Raghuram, nor any peers, have made any analyst calls on ADXN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30